ArticleProceedings of the National Academy of Sciences of the United States of America2026

Tim-3-targeted vaccines overcome tumor immunosuppression and reduce cDC1 dependence to elicit potent anti-tumor immunity.

Chunmei Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.